How and when to use biologics in psoriasis

J Drugs Dermatol. 2010 Aug;9(8 Suppl ODAC Conf Pt 2):s106-17.
No abstract available

Publication types

  • Review

MeSH terms

  • Alefacept
  • Biological Products / adverse effects
  • Biological Products / therapeutic use*
  • Dermatologic Agents / therapeutic use
  • Drug Monitoring
  • Humans
  • Psoriasis / therapy*
  • Recombinant Fusion Proteins / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Biological Products
  • Dermatologic Agents
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Alefacept